Codexis to Report Third Quarter 2026 Financial Results on November 12
Key Highlights
- ➤Codexis will report Q3 2026 financial results November 12 after market close
- ➤Management will host a 4:30 p.m. Eastern conference call and webcast
- ➤Codexis is developing ECO Synthesis for scaled enzymatic RNAi therapeutics manufacturing
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the third quarter of 2026 on Thursday, November 12, 2026, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update.
Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international). A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635.
Get started
Create a free account to read the full story.